URI Description
sg:pub.10.1186/s40249-018-0436-1 Cyclical cholera outbreaks in Ghana: filth, not myth
sg:pub.10.3329/jhpn.v29i5.8895 Five Pond-centred Outbreaks of Cholera in Villages of West Bengal, India: Evidence for Focused Interventions
sg:pub.10.1038/550009a Make plans to eliminate cholera outbreaks
sg:pub.10.1007/s11274-007-9481-9 Detection and molecular characterization of Vibrio cholerae O1 Inaba biotype El Tor strain in Kerala, S. India
sg:pub.10.1186/s40249-016-0192-z Assessment of the response to cholera outbreaks in two districts in Ghana
sg:pub.10.1023/b:ejep.0000027353.70796.25 Molecular Epidemiology of Diarrhoeagenic Escherichia ColiAssociated with Sporadic Cases and Outbreaks of Diarrhoea between 2000 and 2001 in India
sg:pub.10.1186/s12879-017-2824-8 Alkaline peptone water enrichment with a dipstick test to quickly detect and monitor cholera outbreaks
sg:pub.10.1186/1471-2458-14-1167 Descriptive characterization of the 2010 cholera outbreak in Nigeria
sg:pub.10.1023/a:1013111016642 Marine ecosystems and cholera
sg:pub.10.1186/1471-2334-1-1 Endemic and epidemic dynamics of cholera: the role of the aquatic reservoir
sg:pub.10.1186/s13104-017-2728-0 Large cholera outbreak in Brong Ahafo Region, Ghana
sg:pub.10.1007/bf02727829 Controlling cholera outbreaks
sg:pub.10.1038/054026b0 Cholera in Indian Cantonments, and how to deal with it
sg:pub.10.1186/1471-2334-14-392 Cholera outbreaks (2012) in three districts of Nepal reveal clonal transmission of multi-drug resistant Vibrio choleraeO1
sg:pub.10.1186/1476-072x-7-44 Spatial and demographic patterns of Cholera in Ashanti region - Ghana
sg:pub.10.3329/jhpn.v31i1.14744 Time Series Analysis of Cholera in Matlab, Bangladesh, during 1988-2001
sg:pub.10.1038/s41564-017-0055-9 Reduction in cholera deaths targeted for 2030
sg:pub.10.1007/s10661-017-6424-2 Waterborne outbreaks in diarrhoea endemic foci of India: a longitudinal exploration and its implications
sg:pub.10.1186/s12889-017-4803-9 Epidemiological link of a major cholera outbreak in Greater Accra region of Ghana, 2014
sg:pub.10.1007/s11845-013-0966-2 In a time of cholera
sg:pub.10.1186/s41043-015-0021-1 An outbreak of cholera in Medipally village, Andhra Pradesh, India, 2013
sg:pub.10.1038/231536a0 Cholera and Prostaglandins
sg:pub.10.1038/srep03710 Epidemic cholera spreads like wildfire
sg:pub.10.1186/1471-2180-9-275 Molecular characterisation of Vibrio choleraeO1 strains carrying an SXT/R391-like element from cholera outbreaks in Kenya: 1994-2007
sg:pub.10.1186/1476-072x-6-25 Geographical structures and the cholera epidemic in modern Japan: Fukushima prefecture in 1882 and 1895
sg:pub.10.1186/2049-9957-3-37 Interaction between climatic, environmental, and demographic factors on cholera outbreaks in Kenya
sg:pub.10.1023/a:1007547117763 Outbreak of cholera in Ibadan, Nigeria
sg:pub.10.1186/1476-072x-7-31 Seasonality of cholera from 1974 to 2005: a review of global patterns
sg:pub.10.1038/149191c0 Public Health in India
sg:pub.10.3329/jhpn.v31i2.16381 Molecular Characterization of the Circulating Strains of Vibrio cholerae during 2010 Cholera Outbreak in Nigeria
sg:pub.10.1186/s12864-017-4254-9 Genetic relatedness of Vibrio cholerae isolates within and between households during outbreaks in Dhaka, Bangladesh
sg:pub.10.1186/s13561-017-0182-2 Economic evaluation of 2014 cholera outbreak in Ghana: a household cost analysis
sg:pub.10.1007/s40070-017-0062-3 Critical success factors for implementing cholera vaccination campaigns in humanitarian emergencies: a DEMATEL-based approach
sg:pub.10.1023/a:1024829328204 Sociomedical indicators in the cholera epidemic in Ferrara of 1855
sg:pub.10.1007/s12275-011-0317-9 Molecular characterization reveals involvement of altered el tor biotype Vibrio cholerae O1 strains in cholera outbreak at Hyderabad, India
sg:pub.10.1038/s41598-018-37706-0 Epidemiological and molecular forensics of cholera recurrence in Haiti
sg:pub.10.1038/srep08923 Using Mobile Phone Data to Predict the Spatial Spread of Cholera
sg:pub.10.1007/s00284-014-0725-2 Assessing Clonal Correlation of Epidemic Vibrio cholerae Isolates During 2011 in 16 Provinces of Iran
sg:pub.10.1007/s00430-015-0433-y Vibrio cholerae O1 El Tor variant and emergence of Haitian ctxB variant in the strains isolated from South India
sg:pub.10.1007/s12088-009-0007-z Antimicrobial susceptibility and molecular characterization of Vibrio cholerae from cholera outbreaks in Chennai
sg:pub.10.1007/s12275-008-0162-7 Molecular characterization of Vibrio cholerae isolates from cholera outbreaks in north India
sg:pub.10.1186/s13104-017-2756-9 Health seeking behaviour among suspected cases of cholera in Cameroonian health districts in Lake Chad basin
sg:pub.10.1007/bf01071953 A bioptic study of gastrointestinal mucosa in cholera patients during an epidemic in Southern Italy
sg:pub.10.1007/bf01593177 The changing assessments of John Snow's and William Farr's cholera studies
sg:pub.10.1186/1471-2458-12-442 Elevation and cholera: an epidemiological spatial analysis of the cholera epidemic in Harare, Zimbabwe, 2008-2009
sg:pub.10.1038/069155a0 <i>Medical Report of the Local Government Board</i><sup>1</sup>
sg:pub.10.3329/jhpn.v28i4.6036 Is <i>Vibrio fluvialis</i> Emerging As a Pathogen with Epidemic Potential in Coastal Region of Eastern India Following Cyclone <i>Aila</i>?
sg:pub.10.1007/s12664-009-0020-5 Cholera outbreak secondary to contaminated pipe water in an urban area, West Bengal, India, 2006
sg:pub.10.1186/1471-2334-6-17 Field evaluation of a rapid immunochromatographic dipstick test for the diagnosis of cholera in a high-risk population
sg:pub.10.1038/104275a0 <i>Influenza: A Discussion opened by Sir Arthur Newsholme</i>
URI Description
sg:pub.10.1007/978-94-017-3284-0_12 Marine ecosystems and cholera
sg:pub.10.1007/978-3-0348-7090-0_56 Studies on Vibrio parahaemolyticus Infection in Calcutta as Compared to Cholera Infection
sg:pub.10.1007/82_2013_353 When, How, and Where can Oral Cholera Vaccines be Used to Interrupt Cholera Outbreaks?
sg:pub.10.1007/978-3-319-38884-7_15 Using Local Weather and Geographical Information to Predict Cholera Outbreaks in Hanoi, Vietnam
sg:pub.10.1007/82_2013_331 The Cholera Outbreak in Haiti: Where and How did it begin?
sg:pub.10.1007/82_2014_362 Cholera Outbreaks in South-East Asia
sg:pub.10.1007/82_2014_369 Cholera Outbreaks in Africa
sg:pub.10.1007/978-3-319-29643-2_17 Portfolio Decision Technology for Designing Optimal Syndemic Management Strategies
sg:pub.10.1007/82_2013_360 Circulation and Transmission of Clones of Vibrio cholerae During Cholera Outbreaks
sg:pub.10.1007/82_2013_361 Cholera Outbreaks in the Classical Biotype Era
sg:pub.10.1007/978-981-10-7368-7_6 Japanese, International Migrants, and Cholera in the Yokohama Treaty Port, 1859–1899
sg:pub.10.1007/978-0-387-74537-4_12 Campylobacter and Arcobacter
sg:pub.10.1007/978-1-349-24355-6_9 Delightfully and Fearlessly Boyish
sg:pub.10.1007/82_2013_358 Role of Phages in the Epidemiology of Cholera
sg:pub.10.1007/978-3-319-67074-4_26 Enhancing Cholera Outbreaks Prediction Performance in Hanoi, Vietnam Using Solar Terms and Resampling Data
sg:pub.10.1007/978-3-319-43148-2_1 Cholera in Oceania
sg:pub.10.1007/978-94-010-3347-3_11 Panel Discussion on Epidemiological Approach
sg:pub.10.1007/82_2013_307 Modeling Cholera Outbreaks
sg:pub.10.1007/978-1-4613-2343-3_8 Differential Diagnosis Between African Swine Fever and Hog Cholera
sg:pub.10.1007/978-1-62703-185-1_5 Molecular Typing of Vibrio cholerae: Imprints in the Epidemiology of Cholera
sg:pub.10.1385/1-59259-238-4:171 Analysis of 16S-23S rRNA Intergenic Spacer of Vibrio cholerae and Vibrio mimicus for Detection of These Species
sg:pub.10.1007/82_2014_363 Cholera Outbreaks in the El Tor Biotype Era and the Impact of the New El Tor Variants
sg:pub.10.1007/978-3-642-69508-7_9 Effect of Cholera Enterotoxin on Intestinal Permeability
sg:pub.10.1007/978-1-349-20527-1_15 Afterword: A Christian Vision of the Future of South Africa
sg:pub.10.1007/978-0-387-93835-6_9 Outbreak Investigations
sg:pub.10.1007/978-1-60327-265-0_5 The Re-emergence of Cholera in the Americas
sg:pub.10.1007/978-1-60327-265-0_7 Molecular Epidemiology of Toxigenic Vibrio cholerae
sg:pub.10.1007/978-94-009-6735-9_12 Influence of Salinity, Nutrient Concentration and Temperature on Growth and Survival of Vibrio Choleras in the Aquatic Environment
sg:pub.10.1057/9780230304628_8 ‘This Revived Old Plague’1: Coping with Flu
sg:pub.10.1007/978-3-319-10608-3_4 Management of Ships’ Ballast Water and Biofouling
sg:pub.10.1007/978-1-4613-2083-8_10 Epizootiology of Hog Cholera
sg:pub.10.1007/978-94-009-6735-9_16 Isolation of Hybridoma Cell Lines Producing Antibody against Cholera Enterotoxin
sg:pub.10.1007/978-3-540-88452-1_12 Cholera Toxin (CT): Immune Response of the Host and Vaccine Production
sg:pub.10.1007/978-1-60327-265-0_1 General Introduction
sg:pub.10.1057/9781137394996_2 Logbook of an HIV-Positive Voyage
sg:pub.10.1007/978-1-4614-1686-9_9 Epidemic Models
sg:pub.10.1007/978-1-4614-5283-6_70 Quarantine and Isolation
sg:pub.10.1007/978-1-4684-2337-2_44 Alcohol and Education
sg:pub.10.1007/978-1-60327-265-0_4 Phenotypic and Molecular Characteristics of Epidemic and Non-epidemic Vibrio cholerae Strains Isolated in Russia and Certain Countries of Commonwealth of Independent States (CIS)
sg:pub.10.1007/978-1-4612-3508-8_16 Protective Antigens of Vibrio Cholerae
sg:pub.10.1007/978-3-0348-7090-0_68 Epidemiological Studies on Cholera in Non-Endemic Regions with Special Reference to the Problem of Carrier State during Epidemic and Non-Epidemic Period
sg:pub.10.1007/978-1-4757-9688-9_10 Pathogenesis
sg:pub.10.1007/978-94-009-4990-4_6 Epidemiology of Bacterial Diarrhoeal Diseases in India with Special Reference to Vibrio Parahaemolyticus Infections
sg:pub.10.1007/82_2014_368 Cholera Outbreaks in India
sg:pub.10.1007/978-3-540-88452-1_14 Concluding Notes
sg:pub.10.1007/978-3-662-41323-4_9 Grundsätze für Maßnahmert im Eisenbahnverkehre beim Auftreten der Cholera
sg:pub.10.1007/978-3-662-41323-4_8 Wie schützt sich der Schiffer vor der Cholera?
sg:pub.10.1007/978-94-011-5390-4_6 Mechanism of Cholera
sg:pub.10.1007/978-1-60327-265-0_19 Management of Cholera
sg:pub.10.1007/978-94-017-3459-2_21 Avian disease at the Salton Sea
URI Description
sg:grant.6618405 Epidemiology and Ecology of Cholera in Africa
sg:grant.2453408 Epidemiology and Ecology of Vibrio cholerae in Bangladesh
sg:grant.4579521 Multidisciplinary studies in the ecology and epidemiology of cholera to predict epidemics.
sg:grant.3849908 A Joint Mathematical and Experimental Study on Cholera Transmission Dynamics
sg:grant.2669135 Effects of Climate Change on Cholera Dynamics and Prediction
sg:grant.2459576 Assessing measures to eliminate transmission of cholera in Haiti
sg:grant.3126740 Modeling the Effects of Heterogeneity in Water Quality on Cholera Disease Dynamics
sg:grant.5476002 Cholera transmission and evolution in Port-au-Prince, Haiti
sg:grant.3624392 Vibrio cholerae biofilms: structure, function, regulation and role in infection
sg:grant.2456225 Study of transmissible forms of Vibrio Cholerae
sg:grant.5231895 Dynamics and controls of large-scale cholera outbreaks
sg:grant.2599899 Regulation of the Vibrio cholerae intestinal exit plan
sg:grant.3063644 EID: Collaborative Research: The Interplay of Extrinsic and Intrinsic Factors in Epidemiological Dynamics: Cholera as a Case Study
sg:grant.2665958 Smooth to Rugose phase variation in Vibrio cholerae
sg:grant.3051598 EID: Collaborative Research: The Interplay of Extrinsic and Intrinsic Factors in Epidemiological Dynamics: Cholera as a Case Study
sg:grant.5237979 Phylogenomic framework for virulence studies of Vibrio cholerae
sg:grant.5124292 Vibrio cholerae-chitin interactions and their role in cholera transmission and evolution
sg:grant.2401707 Molecular Pathogenesis of Enterotoxigenic Escherichia coli Infections
sg:grant.2519902 The ecology of environmentally maintained episodic anthrax in Esotha, Namibia
sg:grant.2376486 Retrotranslocation of cholera toxin AI-chain from ER ot cytosol and cell response
sg:grant.6442664 Phage resistance and mobile genetic elements in Vibrio cholerae
sg:grant.3536909 O-Specific Polysaccharide Responses and Cholera
sg:grant.2417342 Estimation of Intervention Effects in Influenza Outbreaks
sg:grant.2688011 High throughput NAPPA-proteoimmunomics and Vibrio cholerae vaccine development
sg:grant.2687680 Protecutive immunity to human cholera in Bangladesh
sg:grant.2459779 Innate and early B cell responses to V. cholerae
sg:grant.4055418 A Household Yeast Biosensor for Cholera
sg:grant.2410256 High-throughput proteomic study of protective immunity in human cholera infection
sg:grant.2520720 Role of host fucose in cholera toxin action
sg:grant.2457681 Genetic and Ecological Factors in Transmissibility and Epidemic Cycle of Cholera
sg:grant.5503922 Humoral and adaptive immune responses study in Vibrio cholerae infection
sg:grant.2449670 CHOLERA--PATHOGENESIS AND IMMUNOLOGY
sg:grant.6580650 To understand the burden of disease for cholera in Africa and build evidence to support cholera vaccine adoption there
sg:grant.3581968 Collaborative Research: Wildlife subsidies interact with discharge to influence ecosystem function of a large African river
sg:grant.3580394 Collaborative Research: Wildlife subsidies interact with discharge to influence ecosystem function of a large African river
sg:grant.5363389 Effect of protamine and cholera toxin on the expression of proteins of the tight junctions of the epithelium and the permeability of various departments of the rat intestine
sg:grant.4957964 Its relationship with the popular Screening cholera epidemic of the environmental advantages of intermittent clonal populations
sg:grant.2453981 Vibrio cholerae intestinal colonization and vaccine development
sg:grant.5237076 Identification of genetic and environmental factors that modulate V. cholerae infectivity and transmission
sg:grant.2405724 T-cell immune responses to Vibrio cholerae infection
sg:grant.2718162 FIELD TRIAL OF ORAL CHOLERA VACCINES IN BANGLADESH
sg:grant.2619151 CHOLERA: PATHOGENESIS AND IMMUNOLOGY
sg:grant.2410285 Immune Responses to Vibrio Cholerae in Children
sg:grant.2518077 Phages and Genomic Variation in Vibrio Cholerae Evolution
sg:grant.4915383 Toxoplasma gondii P30 antigen vaccine research and cholera toxin A2 / B subunit fusion gene
sg:grant.2567100 Mucosal immune response to oral cholera vaccine Peru 15
sg:grant.2452310 Genetic Analysis of Cholera Toxin Structure and Function
sg:grant.3796593 Virulence factors of facultative pathogens and their role outside the human host
sg:grant.2453652 CHOLERA TOXIN--A MUCOSAL ADJUVANT, MECHANISMS &IMMUNITY
sg:grant.4962219 Vibrio cholerae new type CTXφ, nct-CTXφ genome and VPI pathogenicity island
URI Description
sg:patent.US-5631010-A Genetically stable cholera vaccines with deletions of ctxA, recA and attRS1
sg:patent.EP-0368819-A1 Expression of the binding subunit of cholera toxin with the aid of foreign promoters and/or leader sequences
sg:patent.EP-0672116-A1 DELETION MUTANTS AS VACCINES FOR CHOLERA
sg:patent.EP-1073899-A4 IMPROVED METHOD FOR PURIFYING CHOLERA TOXIN
sg:patent.US-5214029-A Inhibition of malignant cells having GM1 ganglo-side sites by administration of cholera toxin
sg:patent.EP-1073899-A1 IMPROVED METHOD FOR PURIFYING CHOLERA TOXIN
sg:patent.US-5874088-A Deletion mutants of cholera vaccines expressing heterologous antigens
sg:patent.US-4328209-A Cholera vaccine
sg:patent.US-5268276-A Recombinant systems for expression of cholera B-sub-unit with the aid of foreign promoters and/or leader peptides
sg:patent.EP-0018154-A2 Vibrio cholerae mutants, vaccine comprising them, method for preparing a subunit therefrom and composition comprising it
sg:patent.EP-0018154-A3 VIBRIO CHOLERAE MUTANT, VACCINE COMPRISING IT, METHOD FOR PREPARING A SUBUNIT THEREFROM AND COMPOSITION COMPRISING IT
sg:patent.US-7041296-B1 Methods of treating inflammatory bowel disease using cholera toxin B subunit
sg:patent.AU-2011238711-B2 High level expression of recombinant toxin proteins
sg:patent.EP-2553102-A2 HIGH LEVEL EXPRESSION OF RECOMBINANT TOXIN PROTEINS
sg:patent.EP-0313846-A3 METHOD FOR CONTROLLING CHRONIC RESPIRATORY DISEASE, FOWL CHOLERA AND NECROTIC ENTERITIS IN AVIAN SPECIES
sg:patent.FR-2598621-A1 New fraction [0027] obtained by the release, in a culture medium of vibrios cholera, such a fraction and its application for the preparation of a vaccine cholera oral
sg:patent.EP-2553102-B1 HIGH LEVEL EXPRESSION OF RECOMBINANT TOXIN PROTEINS
sg:patent.US-7285281-B2 Mutant forms of cholera holotoxin as an adjuvant
sg:patent.US-5882653-A Vibrio cholerae 01 (CVD111) and non-01 (CVD112 and CVD112RM) serogroup vaccine strains, methods of making same and products thereof
sg:patent.EP-2553102-A4 HIGH LEVEL EXPRESSION OF RECOMBINANT TOXIN PROTEINS
sg:patent.US-6043057-A Recombinant systems for expression of the cholera B-sub-unit with the aid of foreign promoters and/or leader peptides
sg:patent.WO-1994001533-A1 DELETION MUTANTS AS VACCINES FOR CHOLERA
sg:patent.US-8202842-B2 Inhibition of cholera toxins by galatooligosaccharides (GOS)
sg:patent.US-6149919-A Immunogenic detoxified mutants of cholera toxin and of the toxin LT, their preparation and their use for the preparation of vaccines
sg:patent.FR-2722797-A1 Culture medium favoring the growth of endocrine cells
sg:patent.EP-1947110-A1 INTRANASAL VACCINE FOR USE AGAINST DISEASE CAUSED BY ENTEROTOXIGENIC ESCHERICHIA COLI
sg:patent.WO-1998021220-A2 SACCHARIDE DERIVATIVES
sg:patent.US-5811409-A Treatment of cholera
sg:patent.WO-2001072959-A3 PLASTID TRANSFORMATION VECTORS FOR EXPRESSING HUMAN PROTEINS IN PLANTS
sg:patent.EP-0313846-A2 Method for controlling chronic respiratory disease, and necrotic enteritis in avian species
sg:patent.US-5661131-A Treatment of cholera
sg:patent.US-8287855-B2 V. cholerae hyperexpressing recombinant cholera toxin B subunit showing dual immunogenicity
sg:patent.US-6036953-A Heterologous antigens in live cell V. cholerae strains
sg:patent.WO-1998021220-A3 SACCHARIDE DERIVATIVES
sg:patent.US-7384640-B1 Mutant cholera holotoxin as an adjuvant
sg:patent.WO-2013026445-A1 METHOD FOR QUICKLY ISOLATING OR PURIFYING RECOMBINANT PROTEINS USING A (NON-TOXIC) CHOLERA TOXIN DOMAIN
sg:patent.EP-1947110-A4 INTRANASAL VACCINE FOR USE AGAINST DISEASE CAUSED BY ENTEROTOXIGENIC ESCHERICHIA COLI
sg:patent.WO-1999008706-A1 RECOMBINANT PORCINE ADENOVIRUS VECTOR
sg:patent.EP-1825863-A1 Recombinant porcine adenovirus vector
sg:patent.WO-1990007007-A1 CELL CULTURE MEDIUM FOR HUMAN LIVER EPITHELIAL CELL LINE
sg:patent.EP-1007088-A1 RECOMBINANT PORCINE ADENOVIRUS VECTOR
sg:patent.FR-2636842-A1 Fusion protein of sequence derivative the - unit b of the toxin cholera and of an antigen fused gifted of pharmacological immunogenic, vaccine compositions containing them and nucleic acids containing a recombinant nucleotide sequence encoding the fusion protein
sg:patent.US-5342777-A Cell culture medium for human liver epithelial cell line
sg:patent.WO-1990010060-A1 NON-A, NON-B HEPATITIS HEPATOCYTE CELL CULTURE
sg:patent.US-7279169-B1 Mucosal DTPa vaccines
sg:patent.US-5894018-A Vaccine composition comprising autologous epidermal growth factor or a fragment or a derivative thereof having anti-tumor activity and use thereof in the therapy of malignant diseases
sg:patent.EP-1007088-A4 RECOMBINANT PORCINE ADENOVIRUS VECTOR
sg:patent.US-8906636-B2 High level expression of recombinant toxin proteins
sg:patent.US-9511133-B2 Vaccine against cholera and enterotoxigenic E. coli (ETEC) diarrhea
sg:patent.US-7632513-B2 Immunogenic detoxified mutants of cholera toxin
URI Description
sg:clinicaltrial.NCT00289224 A Randomized Controlled Trial of the Bivalent Killed Whole Cell Oral Cholera Vaccine in Eastern Kolkata, West Bengal, India
sg:clinicaltrial.NCT02111304 A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Two-Part Trial to Evaluate the Efficacy, Safety, and Tolerability of iOWH032 in the Treatment of Acute Dehydrating Diarrhea in Adult and Pediatric Patients With Cholera
sg:clinicaltrial.NCT03719586 A Multicenter, Multi-Outbreak, Randomized, Controlled Safety and Efficacy Study of Investigational Therapeutics for the Treatment of Patients With Ebola Virus Disease
sg:clinicaltrial.NCT01377571 A Phase II, Randomized, Double-blind, Vaccine-controlled Dose-escalating Study to Evaluate the Immunogenicity, Reactogenicity and Safety of Oral Live Attenuated Human Rotavirus (HRV) Vaccine (Rotavin-M1) in Healthy Infants in Vietnam
sg:clinicaltrial.NCT01375907 A Phase 1 Study to Evaluate Safety and Reactogenicity of a Vietnamese Rotavirus Vaccine (Rotavin-M1 at 10e6.3FFU/Dose) Among Healthy Adults in Vietnam
sg:clinicaltrial.NCT01821586 Optimisation of Oral Rehydration Solution and Evaluation of the Efficacy of Benefiber(Partially Hydrolyzed Guar Gum) Containing Modified Oral Rehydration Solution in the Treatment of Severely Malnourished Children With Watery Diarrhoea
sg:clinicaltrial.NCT02231047 64N Nutraceutical for the Prevention of Childhood Diarrhea and Pneumonia in Low Resource Settings
sg:clinicaltrial.NCT03177213 Serum IL-21 Levels in Patients With Pemphigus Vulgaris
sg:clinicaltrial.NCT02434133 Cross Sectional Study of Vaccine Antibody Response in Inflammatory Bowel Disease Patients
sg:clinicaltrial.NCT01569581 A Phase III Clinical Trial for Inactivated Enterovirus Type 71 Vaccine (Human Diploid Cell, KMB-17 Cell) in Chinese Infants and Children
sg:clinicaltrial.NCT02666027 The Use of the Fluid IV Alert (FIVA) Monitor to Decrease the Incidence of Undetected Empty Intravenous Bag in Dimmed Operating Rooms
sg:clinicaltrial.NCT00800930 Therapeutic Induction of Endogenous Antibiotics for Improved Recovery in Shigellosis
sg:clinicaltrial.NCT00894036 Epidemiology of Extended-spectrum ß-lactamase (ESBL)-Producing Enteric Gram-negative Bacilli in Swiss Children
sg:clinicaltrial.NCT03503812 Mitigating the Health Effects of Desert Dust Storms Using Exposure-Reduction Approaches: Assessment of Health Outcomes in Children With Asthma and in Adults With Atrial Fibrillation During Desert Dust Storms (With vs Without Interventions)
sg:clinicaltrial.NCT02655874 A Single-centre, Randomised, Observer-blind, Active Comparator-controlled, Superiority Trial of the Immune Response to Six-monthly Versus Annual Standard Dose Inactivated Trivalent Influenza Vaccination in the Elderly
sg:clinicaltrial.NCT00304434 Oseltamivir (Tamiflu) Dosing Strategies for Use During Influenza Prophylaxis (VA01)
sg:clinicaltrial.NCT00821509 STOPFLU: Is it Possible to Reduce the Number of Days Off in Office Work by Improved Hand-hygiene?
sg:clinicaltrial.NCT02903706 Prevalence of Malaria Parasites in People Working in Illegal Gold Mining in French Guiana
sg:clinicaltrial.NCT01498133 Does Skin-to-skin Contact Promote Bacterial Decolonization in Preterm Infants in Neonatal Intensive Care Unit? A Randomized, Single-blinded Controlled Trial
sg:clinicaltrial.NCT02348346 Effect of MVX (Titanium Dioxide) on the Microbial Colonization of Surfaces in an Intensive Care Unit
sg:clinicaltrial.NCT02280876 Randomized, Comparative, Double Blind Controlled Phase II Clinical Trial, to Evaluate the Efficacy of ApE in Patients With Multiple Sclerosis (MS).
sg:clinicaltrial.NCT02513225 Randomized Controlled Trial of an Adapted STD Screening and Risk Reduction Intervention
sg:clinicaltrial.NCT03263403 A Randomized Observer-blinded Controlled Non-inferiority Trial to Evaluate the Immunogenicity of Locally Manufactured Meningococcal ACWY Vaccine 'Ingovax ACWY' in Bangladeshi Healthy Adults.
sg:clinicaltrial.NCT01573637 Six Month, Double Blind, Placebo-controlled Trial of the Efficacy of Raloxifene as an Adjuvant Treatment of the Negative Symptoms of Schizophrenia in Post-menopausal Women
sg:clinicaltrial.NCT03723837 Cross-sectional Study to Assess Persistence of Immunity Conferred by a Single IPV Dose Administered in the Expanded Program on Immunization(EPI) Routine Immunization Schedule
sg:clinicaltrial.NCT01841671 A Phase 4, Randomized, Open-Label Study to Assess Humoral and Intestinal Polio Immunity Following a Three-Dose Trivalent Inactivated Polio Vaccine Schedule Relative to Two Sequential Schedules of IPV/Bivalent Oral Polio Vaccines
sg:clinicaltrial.NCT01735084 Pneumococcal Conjugate Vaccine (PCV) Schedules for the Northern Territory (NT): Randomised Controlled Trial of Booster Vaccines to Broaden and Strengthen Protection From Invasive and Mucosal Infections.
sg:clinicaltrial.NCT03356925 Feasibility, Accuracy, and Effect of Point-of-care Xpert MTB/RIF Ultra and Xpert MTB/RIF Ultra Testing in Patients Suspected of Having TB: a Randomised Controlled Trial
sg:clinicaltrial.NCT02644135 A Pilot Study of the Safety, Tolerability, and Effectiveness of Halo to Prevent Acute Upper Respiratory Disease and Respiratory Virus Infections
URI Description
sg:pub.10.1007/978-3-642-55404-9 Cholera Outbreaks
sg:pub.10.1007/978-3-662-41323-4 Anweisung zur Bekἁmpfung der Cholera
sg:pub.10.1007/978-1-60327-265-0 Epidemiological and Molecular Aspects on Cholera
sg:pub.10.1007/978-1-4757-9688-9 Cholera
sg:pub.10.1007/978-94-009-6735-9 Advances in Research on Cholera and Related Diarrheas
sg:pub.10.1007/978-3-540-88452-1 Cholera Toxins
sg:pub.10.1007/978-3-662-41298-5 Bericht über die Thätigkeit der zur Erforschung der Cholera im Jahre 1883 nach Egypten und Indien entsandten Kommission
sg:pub.10.1007/978-94-009-1515-2 Cholera and the Ecology of Vibrio cholerae
sg:pub.10.1007/978-94-011-4337-0 Grasshoppers and Grassland Health, Managing Grasshopper Outbreaks without Risking Environmental Disaster
sg:pub.10.1007/978-94-010-0830-3 Scientific and Technical Means of Distinguishing Between Natural and Other Outbreaks of Disease
sg:pub.10.1007/978-1-59745-501-5 Foodborne Diseases
sg:pub.10.1007/978-0-933876-12-5 Deadly Season, Analyzing the 2011 Tornado Outbreaks
URI Description
sg:person.0623475023.52 Shila Cholera
sg:person.01173232150.02 Rushina Cholera
URI Description
grid-institutes:grid.419566.9 National Institute of Cholera and Enteric Diseases
grid-institutes:grid.414142.6 International Centre for Diarrhoeal Disease Research
URI Description
grid-institutes:grid.419566.9 National Institute of Cholera and Enteric Diseases
grid-institutes:grid.414142.6 International Centre for Diarrhoeal Disease Research